India has developed a novel antibiotic to fight antimicrobial resistance (AMR), as well as a new drug to tackle burden of ...

Japan's AMR response from 2013 to 2025 focuses on surveillance, antimicrobial stewardship, infection prevention, and research ...

CITRYLL DEMONSTRATES A BROADER THERAPEUTIC POTENTIAL FOR CIT-013 IN THE TREATMENT OF INFLAMMATORY DISORDERS Breakthrough ...

(NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare ...

One Health is a global initiative led by the 'Quadripartite' to address health risks at the human-animal-ecosystems interface ...

Basilea Pharmaceutica may finally be able to bring its antibiotic ceftobiprole to ... but that was expected given the drug's mechanism of action. Ceftobiprole has qualified infectious disease ...

In a nutshell Scientists discovered that fluoxetine (Prozac) protects against deadly infections in two ways: by directly ...

Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

Fluoxetine This medication is an antidepressant, prescribed for depression and anxiety. It is also used for obesity and ...

Advances in medical sciences have reduced infectious disease mortality, but emerging pathogens pose global health threats.

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

Ukraine, WHO Representative in Ukraine and Head of the WHO Country Office, Jarno Habicht, speaks about the biggest challenges ...